The invention relates to a
drug for
bone injury treatment, which is orally taken and comprises the following components in parts by weight:
angelica sinensis 16 to 20 portions, rhiaoma liguistici 13 to 17 portions, safflower 8 to 12 portions, angelica 13 to 17 portions,
eagle wood 13 to 17 portions,
drynaria 8 to 10 portions, Chinese wolfberry root-
bark 16 to 20 portions, atractylodes 10 to 14 portions, danshen root 18 to 22 portions,
rhizome polygoni cuspidati 13 to 17 portions, divaricate
saposhnikovia root 10 to 14 portions, ramulus mori 18 to 32 portions, Mujian 10 to 14 portions; while the ingredients weight proportion for topical herbal
medicine composition being:
angelica sinensis 23 to 27 portions, rhiaoma liguistici 13 to 17 portions, largehead atractylodes
rhizome 13 to 17 portions,
oyster 18 to 22 portions, safflower 6 to 10 portions, angelica 16 to 22 portions, panpax notoginseng 8 to 12 portions, atractylodes 13 to 17 portions, north Indian epimeredi
herb 8 to 12 portions, nutgrass flatsedge 8 to 12 portions, Chinese wolfberry root-
bark 16 to 20 portions, ramulus mori 18 to 22 portions, danshen root 18 to 32 portions, radix scrophulariae 23 to 27 portions, radix saussureae lappae 10 to 14 portions; the orally administrated herbal
medicine composition has the functions of activating
collateral flow, removing
blood stasis and
elimination toxin, resuscitating, removing swollen, relieving pain, benefiting qi and promoting
blood circulation; the topical herbal
medicine composition has the functions of promoting
blood circulation, removing
blood stasis, cooling blood, dissipating
hematocele, removing swollen, relieving pain, moisturizing
skin, and activating
collateral flow of the
long bone.